Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07451873

Glycocalyx and Oxidative Stress in Endothelial Function (Part 2)

The Role of Glycocalyx and Oxidative Stress in Endothelial Function (Part 2)

Status
Recruiting
Phase
Study type
Observational
Enrollment
35 (estimated)
Sponsor
Josip Juraj Strossmayer University of Osijek · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary research objective of the project is to determine the role of eGC in microvascular reactivity in patients with coronary heart disease (CHD) before and after bypass grafting (cross-sectional study 2).The main objective of the project is to increase the excellence and interdisciplinarity of scientific work at MEFOS by connecting researchers from different scientific fields, improving conditions and resources for scientific work, and increasing international cooperation, in line with strategic objective 1: raising scientific excellence. The results of the project could provide pathophysiological insight into the development and maintenance of endothelial dysfunction in CVD, as well as identify new biomarkers for CVD.

Detailed description

The primary objective of this project is to determine the association between endothelial glycocalyx (eGC) and myocardial revascularization in patients undergoing coronary artery bypass grafting and clinical outcomes of treatment (observational prospective study 2). Specific objective 2.1: Measure eGC thickness in coronary artery disease patients before and after surgery. Specific objective 2.2: Determine the reactivity of the bypass graft sample in in vitro experiments. Specific objective 2.3: Quantify soluble markers of eGC, oxidative stress, and inflammation from serum and PBMC samples, as well as antioxidant capacity. Specific objective 2.4: Determine the association between the results of functional tests, eGC, and markers from specific objective 2.3 with clinical outcomes of treatment.

Conditions

Timeline

Start date
2025-10-01
Primary completion
2029-09-30
Completion
2029-09-30
First posted
2026-03-05
Last updated
2026-03-09

Locations

1 site across 1 country: Croatia

Source: ClinicalTrials.gov record NCT07451873. Inclusion in this directory is not an endorsement.